VeriMomIst jasminum officinale flower/leaf extract in der Schwangerschaft sicher?
No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
Pregnancy-safe products containing jasminum officinale flower/leaf extract
Related ingredients
Frequently asked questions
- Ist jasminum officinale flower/leaf extract in der Schwangerschaft sicher?
- No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
- Ist jasminum officinale flower/leaf extract während des Stillens sicher?
- No evidence of reproductive/ developmental toxicity or lactation transfer reported in SCCS/CIR or peer‑reviewed literature for this extract. Systemic absorption from typical topical cosmetic use is low but measurable, so breastfeeding exposure is scored as low (1). Sources: CIR (no specific restriction), CosIng, PubChem.
- Ist jasminum officinale flower/leaf extract sicher für Babyhaut?
- No infant‑specific reproductive or developmental hazards identified. Mechanistic data lacking. Because infants (0–3 yr) have higher dermal absorption and surface‑area‑to‑weight ratio, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Note: this does not indicate intrinsic reproductive hazard but reflects higher potential exposure through immature skin. Sources: CosIng, PubChem, general toxicological principles on infant skin permeability.
- Wie bewertet VeriMom jasminum officinale flower/leaf extract?
- VeriMom bewertet jasminum officinale flower/leaf extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu jasminum officinale flower/leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu jasminum officinale flower/leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.